STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Cardiff Lexington Announces 1st Quarter 2021 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Cardiff Lexington Corporation (CDIX) recently reported its financial results for Q1 2021, revealing a net loss of $1,574,267, a 72% improvement from the previous year's loss of $5,575,757. The loss per share decreased by over 89%, amounting to (5.33), compared to (48.93) in Q1 2020. Notably, the company reported a net positive change of $3,977,394 year-over-year. Additionally, cash and cash equivalents rose to $510,760 from $99,860, highlighting improved liquidity. Cardiff Lexington's management aims to reduce convertible debt and enhance its acquisition strategy in healthcare and financial services.

Positive
  • Net loss decreased 72% from $5,575,757 to $1,574,267.
  • Loss per share reduced from (48.93) to (5.33), indicating substantial improvement.
  • Positive net change of $3,977,394 year-over-year.
  • Cash and cash equivalents rose from $99,860 to $510,760.
Negative
  • None.

FT. LAUDERDALE, FL / ACCESSWIRE / May 18, 2021 / Cardiff Lexington Corporation (OTC PINK:CDIX) announced today financial results for its quarter ended March 31, 2021.

Net Income
Net Income For the Three Months Ended March 31,,2020
$ (5,575,757)
Net Loss For the Three Months Ended March 31, 2021
$ (1,574,267)
Net Positive Change
$ 3,977,394
Loss Per Share from Continuing Operations
For the Three Months Ended March 31,,2020
$ (48.93)
For the Three Months Ended March 31, 2021
$ (5.33)
Net Positive Change
$ 43.60
Cash and Cash Equivalents End of Period
For the Three Months Ended March 31,,2020
$ 99,860
For the Three Months Ended March 31, 2021
$ 510,760
Net Positive Change
$ 410,900
Convertible Notes Payable
For the Three Months Ended March 31,,2020
$ 2,476,647
For the Three Months Ended March 31, 2021
$ 1,682,170
Net Positive Change
$ 794,477

"We are excited by our recent results and the significant progress made year over year to net income. The Company has weathered trying economic times and a shift of focus, while remaining committed to reducing our long term dependence on convertible debt. In just the past 90 days we have reduced convertible debt by over three quarters of a million dollars, reduced our loss per share from the same quarter last year by over 89%, with a nearly four million dollar positive impact to net income; dramatically reducing losses across the board", said Alex Cunningham, Cardiff Lexington CEO. We have far more cash on hand than recent quarters. We have finished the PCAOB audit of one or our acquisition targets and thereby expect to add another subsidiary company that is closely aligned with our growth strategy in the healthcare and financial services sectors. There is much more to do, but today, we celebrate the accomplishments of our dedicated team all of whom continue to strive tirelessly to implement our long term strategy. We greatly appreciate our shareholders, and their patience, and take our fiduciary responsibility very seriously. We understand we have a long way to go, but firmly believe that over time the market always recognizes performance.

Cardiff Lexington's acquisition strategy is driven by structure, transaction value, alignment, resources and return on investment. Management targets acquisition of middle market private niche healthcare and financial services companies with high growth potential. The Cardiff Lexington umbrella enables business owners to exit personal equity and to take advantage of the capitalization power of a public company to drive growth and expansion.

About Cardiff Lexington Corporation: Cardiff Lexington employs a "Buy and Build" acquisition and value creation strategy targeting acquisition of middle market private niche financial services and healthcare companies and real estate with synergies leveraging data and resources across similar target markets. The Company is a diversified financial services holding company historically focusing on tax, debt, and real estate sectors. The Company is implementing a buy and build strategy leveraging proven management in private companies that become subsidiaries. Cardiff Lexington targets acquisitions of mature, high growth, niche companies. Cardiff Lexington's strategy identifies and empowers select income-producing middle market private businesses and commercial real estate properties. Cardiff Lexington provides these companies both 1) the enhanced ability to raise money for operations or expansion, 2) an equity exit and liquidity strategy for the owner, heirs, and/or Investors, and 3) a proven experienced Cardiff Lexington management team to lead growth and expansion.

Cardiff Lexington is led by strong and talented team of executives and advisors providing expert acquisition, market guidance and added management value for subsidiaries and investors. For investors, Cardiff Lexington provides a diversified lower risk to protect and safely enhance their investment by continually adding assets and holdings.

FORWARD LOOKING STATEMENT: This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. These risks include the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In the light of these uncertainties the forward-looking events referred to in this release might not occur.

Contact:

Investors Relations 888-507-CDIX (2349) ext. 705
investorsrelations@cardifflexington.com

SOURCE: Cardiff Lexington Corporation



View source version on accesswire.com:
https://www.accesswire.com/647899/Cardiff-Lexington-Announces-1st-Quarter-2021-Financial-Results

FAQ

What are Cardiff Lexington's financial results for Q1 2021 (CDIX)?

Cardiff Lexington reported a net loss of $1,574,267 for Q1 2021, significantly reduced from $5,575,757 in Q1 2020.

How did Cardiff Lexington's loss per share change in Q1 2021?

The loss per share improved from (48.93) in Q1 2020 to (5.33) in Q1 2021.

What was the cash position of Cardiff Lexington at the end of Q1 2021?

As of March 31, 2021, Cardiff Lexington had cash and cash equivalents of $510,760, up from $99,860 a year earlier.

What is the net positive change reported by Cardiff Lexington for Q1 2021?

Cardiff Lexington reported a net positive change of $3,977,394 year-over-year for Q1 2021.

CARDIFF LEXINGTN CORP

OTC:CDIX

CDIX Rankings

CDIX Latest News

CDIX Stock Data

97.74M
12.98M
13.7%
0.01%
Asset Management
Financial Services
Link
United States of America
Las Vegas